Sign in

CIK 0001812364

  • Large accelerated filer

Relay Therapeutics, Inc.

Sign in to watch
Ticker
RLAY
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 617-370-8837
Business address
60 HAMPSHIRE STREET, CAMBRIDGE, MA, 02139
  1. 4 Open-market sale Chief Financial Officer sold 1,695 shares at $6.38 ($10,814)
  2. 4 Open-market sale President, R&D sold 2,686 shares at $6.38 ($17,137)
  3. 4 Open-market sale Chief Financial Officer sold 348 shares at $7.70 ($2,680)
  4. 4 Open-market sale President, R&D sold 765 shares at $7.70 ($5,891)
  5. 4 Open-market sale See remarks sold 298 shares at $7.70 ($2,295)
  6. 4 Open-market sale Chief Legal Officer sold 348 shares at $7.70 ($2,680)
  7. 4 Open-market sale See remarks sold 1,651 shares at $9.64 ($15,916)
  8. 4 Open-market sale Chief Financial Officer sold 2,005 shares at $9.64 ($19,328)
  9. 4 Open-market sale President, R&D sold 3,178 shares at $9.64 ($30,636)
  10. 4 Open-market sale Chief Legal Officer sold 1,929 shares at $9.64 ($18,596)
  11. 4 Grant or award See remarks acquired 200,000 shares (grant or award)
  12. 4 Grant or award President and CEO acquired 762,360 shares (grant or award)
  13. 4 Grant or award Chief Financial Officer acquired 200,000 shares (grant or award)
  14. 4 Grant or award President, R&D acquired 300,000 shares (grant or award)
  15. 4 Grant or award Chief Legal Officer acquired 200,000 shares (grant or award)
  16. 4 Open-market sale See remarks sold 244 shares at $11.51 ($2,808)
  17. 4 Open-market sale Chief Financial Officer sold 294 shares at $11.51 ($3,384)
  18. 4 Open-market sale President, R&D sold 977 shares at $11.51 ($11,245)
  19. 4 Open-market sale Chief Legal Officer sold 294 shares at $11.51 ($3,384)
  20. 4 Open-market sale See remarks sold 1,354 shares at $6.03 ($8,165)

Page 7 of 16 · 320 filings